Provider Profile Name: Ivy Rx
Website: ivyrx.com
Provider Type: Telehealth — Virtual Only, Direct-to-Consumer
Operating Details
- Fully virtual — online assessment, asynchronous provider consultation, home delivery
- No insurance required; HSA/FSA eligible with itemized receipts provided instantly
- No lab work required before prescribing
- Flat pricing at every dose — same cost regardless of titration level
- Free shipping; temperature-controlled packaging
- Consultations are typically asynchronous — message-based rather than live video; some states may require face-to-face consultations
- No medical director publicly named
Approach Ivy Rx is an online weight-loss clinic that prescribes GLP-1 medications like semaglutide and tirzepatide in both compounded and brand-name forms — everything done virtually from intake quiz to prescription delivery, with simple pricing, responsive customer service, and fast turnaround as its primary differentiators. The platform’s flat-dose pricing model is one of its clearest competitive advantages in a market where most platforms increase monthly costs as doses escalate.
About the Company
Ivy Rx positions itself as a speed- and simplicity-first platform with a broader wellness catalog alongside its GLP-1 offering. Beyond GLP-1s, Ivy Rx also offers wellness therapies like NAD+, B12, and MIC+B12 injections, peptides, glutathione, and supplements — making it a multi-treatment wellness platform rather than a weight-loss-only service.
A meaningful transparency differentiator: Ivy Rx publicly names its compounding pharmacy partners — Greenwich RX and ERXHub, both 503B/USP <797> compliant — something most platforms in this review series decline to disclose. The 503B designation and USP <797> compliance signals that pharmacy partners operate under FDA-registered, cGMP-aligned manufacturing standards. Patients can independently verify these facilities’ licensure status, which is not possible at platforms that keep pharmacy sourcing undisclosed.
Ivy Rx skips lab work entirely before prescribing GLP-1 medications, which keeps costs and wait times low but means important health markers like thyroid function and kidney health are not checked before treatment begins. Patients with underlying conditions or complex medication histories should discuss this with their prescribing provider.
GLP-1 Offerings and Weight Loss Services
Compounded Medications (primary offering):
- Compounded Semaglutide (injectable) — weekly injection; sourced from 503B/USP <797> compliant pharmacies
- Compounded Tirzepatide (injectable) — dual GLP-1/GIP receptor agonist; weekly injection
Brand-Name Options:
- Ozempic (semaglutide, off-label for weight loss) and Mounjaro (tirzepatide, off-label for weight loss)
Note: The brand-name GLP-1s offered by Ivy Rx are Ozempic and Mounjaro, which are FDA-approved for type 2 diabetes rather than weight loss — their weight-loss-indicated counterparts Wegovy and Zepbound are not listed as available through the platform. Patients seeking weight-loss-indicated brand-name medications should confirm current availability.
Additional Treatments:
- Metformin ER, MIC + B12 injections, a proprietary “GLP-1 Boost” supplement blend (hops extract, beetroot powder, NMN, berberine)
- NAD+ injections, glutathione, peptides
App:
- Ivy Rx app includes weight tracking, exercise logging, meal planning, and scheduling tools
Pricing — and What Reviewers Say
Ivy Rx uses flat pricing at every dose — the same monthly cost regardless of titration level, which is a meaningful differentiator from most platforms where prices increase as doses escalate to therapeutic maintenance levels.
Published pricing:
- Compounded Semaglutide: from approximately $197/month — flat across all doses
- Compounded Tirzepatide: $495/month
- Mounjaro (brand-name): $1,399/month
- MIC + B12 injections: $179/bottle
No additional fees for initial consultations or ongoing provider check-ins — a clean all-inclusive model at each tier.
What reviewers say about pricing: On-site testimonials highlight the cost advantage prominently, with one reviewer noting the compounded semaglutide is approximately one-quarter the cost of the branded version. The flat-dose structure draws particular appreciation from patients who have experienced price escalation at other platforms. The no-insurance, no-lab-required model is consistently cited as a barrier reducer for patients who found brand-name pathways inaccessible.
Reviews from Trustpilot and Google
Ivy Rx has 4,136 Trustpilot reviews at time of writing, representing a substantial independently verified review pool.
What patients praise:
- Customer service responsiveness is the dominant theme — reviewers name individual representatives by name and describe same-day resolution of billing, shipping, and clinical questions
- Fast approval and shipping, with medication arriving within days of intake submission in most cases
- Long-term satisfaction among multi-month patients, including reviewers who have been with the platform for over a year
Common complaints:
- A recurring complaint involves patients reporting no appetite suppression — describing the medication as feeling like a placebo, with no reduction in cravings despite consistent dosing. This pattern appears in multiple independent reviews and warrants attention, as it may reflect variability in compounded product potency across different batch fills
- The asynchronous consultation model means patients without real-time clinical access may experience delays when urgent questions arise about side effects or dosing
Compounding Pharmacies Used
Ivy Rx works with licensed US partner pharmacies including Greenwich RX and ERXHub, both 503B/USP <797> compliant. The 503B designation means these facilities are FDA-registered outsourcing facilities held to cGMP manufacturing standards — a higher regulatory standard than 503A state-regulated compounding pharmacies. Medications are prepared in state-licensed pharmacies, independently verified in FDA- and DEA-registered labs, and delivered in temperature-controlled packaging. The public naming of pharmacy partners is a transparency practice uncommon in the broader compounded GLP-1 telehealth market and worth noting as a positive signal for patients evaluating supply chain oversight.
Note: Ivy Rx’s flat-dose pricing model and public disclosure of named 503B-compliant pharmacy partners (Greenwich RX, ERXHub) are meaningful differentiators in this review series. The 4,136-review Trustpilot pool provides solid independent signal, with customer service consistently praised. A recurring complaint about product inefficacy — multiple reviewers describing zero appetite suppression — should be weighed when evaluating; this pattern may reflect batch variability in compounded products. No lab work is required before prescribing, which may be a limitation for patients with complex medical histories. Compounded medications are not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.





